Morgan Stanley Maintains Equal-Weight on GE HealthCare Techs, Raises Price Target to $78
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on GE HealthCare Techs (NASDAQ:GEHC) and raised the price target from $76 to $78.
July 26, 2023 | 2:58 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on GE HealthCare Techs and raised the price target from $76 to $78.
The news is directly about GE HealthCare Techs. The raised price target indicates a positive outlook from Morgan Stanley, which could lead to increased investor confidence and potentially a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100